Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
289 AUD | -0.17% | +3.18% | +0.82% |
May. 30 | US nears deal to fund Moderna's bird flu vaccine trial, FT reports | RE |
May. 27 | US, European nations consider vaccinating workers exposed to bird flu | RE |
Sales 2024 * | 14.72B 22.32B | Sales 2025 * | 15.93B 24.17B | Capitalization | 91.94B 139B |
---|---|---|---|---|---|
Net income 2024 * | 2.71B 4.11B | Net income 2025 * | 3.26B 4.94B | EV / Sales 2024 * | 6.91 x |
Net Debt 2024 * | 9.82B 14.89B | Net Debt 2025 * | 8.65B 13.12B | EV / Sales 2025 * | 6.31 x |
P/E ratio 2024 * |
33.7
x | P/E ratio 2025 * |
28
x | Employees | 32,065 |
Yield 2024 * |
1.39% | Yield 2025 * |
1.62% | Free-Float | 99.53% |
Latest transcript on CSL Limited
1 day | -0.17% | ||
1 week | +3.18% | ||
Current month | +3.18% | ||
1 month | +4.31% | ||
3 months | +1.24% | ||
6 months | +8.27% | ||
Current year | +0.82% |
Managers | Title | Age | Since |
---|---|---|---|
Paul McKenzie
CEO | Chief Executive Officer | 58 | 19-05-31 |
Director of Finance/CFO | 59 | 20-09-30 | |
Mark Hill
CTO | Chief Tech/Sci/R&D Officer | 62 | 20-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Carolyn Hewson
BRD | Director/Board Member | 69 | 19-12-08 |
Brian McNamee
PSD | President | 68 | 90-06-30 |
Alison Watkins
BRD | Director/Board Member | 61 | 21-08-18 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.91% | 21 M€ | +7.83% | - | |
2.49% | 7 M€ | +11.44% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 289 | -0.17% | 494,656 |
24-06-06 | 289.5 | +1.27% | 648,360 |
24-06-05 | 285.9 | +1.37% | 927,555 |
24-06-04 | 282 | +0.23% | 579,240 |
24-06-03 | 281.3 | +0.44% | 546,335 |
Delayed Quote Australian S.E., June 07, 2024 at 02:11 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.82% | 91.94B | |
-1.32% | 38.74B | |
-12.88% | 32.82B | |
+64.77% | 26.66B | |
-16.31% | 15.32B | |
-11.38% | 11.65B | |
+173.10% | 10.37B | |
-49.84% | 10.12B | |
+5.24% | 9.06B | |
-16.26% | 7.46B |
- Stock Market
- Equities
- CSL Stock